Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2021

Schedule of Earnings Per Share, Basic and Diluted

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(26.9)	$	(32.5)	$	(47.9)	$	(60.0)
Less: amounts allocated to participating securities (1)	—		(9.7)		(10.3)		(19.2)
Net loss attributable to common stockholders	$	(26.9)	$	(42.2)	$	(58.2)	$	(79.2)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	69,267		48,840		62,060		48,661

Loss per share:
Basic and diluted (2)	$	(0.39)	$	(0.86)	$	(0.94)	$	(1.63)

Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
Stock options	2,016		—		1,901		42
Restricted shares	1,484		530		1,451		545

(1)Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.

(2)The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.